7,556.04

-164.35

-2.13%

51,682.29

-660.27

-1.26%

25,353.09

-831.64

-3.18%

2,796.26

-62.96

-2.20%

4.9210

-0.0680

-1.36%

21.11

+3.91

+22.65%

3,887.50

-143.90

-3.57%

76,474.76

-4,268.53

-5.29%

Crude Oil Dec 26

104.38

+2.38

+2.33%

US Private Equity

10,932.82

-7.68

-0.07%

Regeneron Bolts 11% Higher, Breaking Out To A Two-Year High On Dupixent Dominance

Regeneron Bolts 11% Higher, Breaking Out To A Two-Year High On Dupixent Dominance · Investor's Business Daily

ALLISON GATLIN

Fri, October 30, 2026 at 11:48 AM EDT 2 min read

Regeneron stock jumped to a two-year high Friday after its Sanofi-partnered inflammation giant, Dupixent, handily beat expectations.

Continue Reading

Terms and Privacy Policy

Your Privacy Choices

Mobilize your Website

View Site in Mobile | Classic

Share by: